Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Alzamend Neuro, Inc. (ALZN) had Weighted-Average Shares Outstanding (Diluted) of 0.45M for the most recently reported fiscal year, ending 2025-04-30.
| Income Statement Financials | |
-- |
|
$-5.11M |
|
-- |
|
-- |
|
$4.50M |
|
$-4.50M |
|
$-0.02M |
|
$-4.51M |
|
$-4.51M |
|
$-4.51M |
|
$-4.51M |
|
$-4.51M |
|
$-4.51M |
|
$-4.50M |
|
$-4.45M |
|
0.45M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
0.45M |
$-11.32 |
|
$-11.32 |
|
| Balance Sheet Financials | |
$4.18M |
|
$0.43M |
|
$0.43M |
|
$4.60M |
|
$0.63M |
|
-- |
|
-- |
|
$0.63M |
|
$3.97M |
|
$3.97M |
|
$3.97M |
|
0.78M |
|
| Cash Flow Statement Financials | |
$-6.57M |
|
$-0.30M |
|
$10.44M |
|
$0.38M |
|
$3.95M |
|
$3.57M |
|
$0.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-113.78% |
|
-113.78% |
|
-98.09% |
|
-113.78% |
|
$5.10 |
|
$-15.24 |
|
$-14.57 |
|